Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024:2775:225-237.
doi: 10.1007/978-1-0716-3722-7_15.

Quantification of C. neoformans Capsule Diameter

Affiliations

Quantification of C. neoformans Capsule Diameter

Tiffany E Guess et al. Methods Mol Biol. 2024.

Abstract

The polysaccharide capsule of Cryptococcus neoformans is the primary virulence factor and one of the most commonly studied aspects of this pathogenic yeast. Capsule size varies widely between strains, has the ability to grow rapidly when introduced to stressful or low-nutrient conditions, and has been positively correlated with strain virulence. For these reasons, the size of the capsule is of great interest to C. neoformans researchers. Inducing the growth of the C. neoformans capsule is used during phenotypic testing to help understand the effects of different treatments on the yeast or size differences between strains. Here, we describe one of the standard methods of capsule induction and detail two accepted methods of staining: (i) India ink, a negative stain, used in conjunction with conventional light microscopy and (ii) co-staining with fluorescent dyes of both the cell wall and capsule followed by confocal microscopy. Finally, we outline how to measure capsule diameter manually and offer a protocol for automated diameter measurement of India ink-stained samples using computational image analysis.

Keywords: Capsule; Cryptococcus neoformans; Fluorescent stain; Image analysis; India ink; Virulence; Yeast.

PubMed Disclaimer

Similar articles

References

    1. McFadden D, Zaragoza O, Casadevall A (2006) The capsular dynamics of Cryptococcus neoformans. Trends Microbiol 14(11):497–505. https://doi.org/10.1016/j.tim.2006.09.003 - DOI - PubMed
    1. Zaragoza O, Casadevall A (2004) Experimental modulation of capsule size in Cryptococcus neoformans. Biol Proced Online 6:10–15. https://doi.org/10.1251/bpo68 - DOI - PubMed - PMC
    1. McClelland EE, Perrine WT, Potts WK et al (2005) Relationship of virulence factor expression to evolved virulence in mouse-passaged Cryptococcus neoformans lines. Infect Immun 73(10):7047–7050. https://doi.org/10.1128/IAI.73.10.7047-7050.2005 - DOI - PubMed - PMC
    1. Bisson GP, Nthobatsong R, Thakur R et al (2008) The use of HAART is associated with decreased risk of death during initial treatment of cryptococcal meningitis in adults in Botswana. J Acquir Immune Defic Syndr 49(2):227–229. https://doi.org/10.1097/QAI.0b013e318183181e - DOI - PubMed - PMC
    1. Gates MA, Thorkildson P, Kozel TR (2004) Molecular architecture of the Cryptococcus neoformans capsule. Mol Microbiol 52(1):13–24. https://doi.org/10.1111/j.1365-2958.2003.03957.x - DOI - PubMed

MeSH terms

LinkOut - more resources